Bright Angel Therapeutics (BAT) is a pre-clinical stage biotechnology company focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. The company is powered by Schrödinger’s computational drug discovery platform in addition to proprietary technologies which the company has developed to enable design and development of fungal-selective inhibitors. BAT is currently working on two programs targeting invasive fungal infections (see pipeline). The company is headquartered in Toronto, Ontario, Canada.

Bright Angel Therapeutics logo



Event details

Date: November 6 - 8, 2023

Event contact

Patrick Barry
Area Director
Europe: Automotive and Life Sciences


21 in total